CVR number 43947176
Industry 46.4620 Wholesale of pharmaceutical goods

Drevelin Nordic ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
N/A
2020
N/A
2021
N/A
2022
N/A
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 0.0% 0.0% 7.0%  
Credit score (0-100)  0 0 0 0 33  
Credit rating  N/A N/A N/A N/A BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
N/A
2023
2023/12
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 0.0 134  
EBITDA  0.0 0.0 0.0 0.0 43.9  
EBIT  0.0 0.0 0.0 0.0 43.9  
Pre-tax profit (PTP)  0.0 0.0 0.0 0.0 43.5  
Net earnings  0.0 0.0 0.0 0.0 34.0  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 0.0 43.5  
 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
N/A
2023
2023/12
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 0.0 0.0 74.0  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 626  
Balance sheet total (assets)  0.0 0.0 0.0 0.0 1,290  
Net Debt  0.0 0.0 0.0 0.0 -136  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
N/A
2022
N/A
2023
2023/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 0.0 134  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Employees  0 0 0 0 2  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 0 1,290  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% 0.0%  
Added value  0.0 0.0 0.0 0.0 43.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 0.0 1.0  

Profitability 
2019
N/A
2020
N/A
2021
N/A
2022
N/A
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% 0.0% 32.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% 0.0% 3.4%  
ROI %  0.0% 0.0% 0.0% 0.0% 6.3%  
ROE %  0.0% 0.0% 0.0% 0.0% 45.9%  

Solidity 
2019
N/A
2020
N/A
2021
N/A
2022
N/A
2023
2023/12
Equity ratio %  0.0% 0.0% 0.0% 0.0% 5.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% 0.0% -309.5%  
Gearing %  0.0% 0.0% 0.0% 0.0% 846.3%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.1%  

Liquidity 
2019
N/A
2020
N/A
2021
N/A
2022
N/A
2023
2023/12
Quick Ratio  0.0 0.0 0.0 0.0 0.9  
Current Ratio  0.0 0.0 0.0 0.0 1.1  
Cash and cash equivalent  0.0 0.0 0.0 0.0 761.9  

Capital use efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
N/A
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 0.0 74.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
N/A
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 22  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 22  
EBIT / employee  0 0 0 0 22  
Net earnings / employee  0 0 0 0 17